Biohaven Announces Orphan Drug Designation Request Granted For BHV-0223 In The Treatm
Biohaven Announces Orphan Drug Designation Request Granted For BHV-0223 In The Treatment Of Amyotrophic Lateral Sclerosis ("ALS")
Biohaven Announces Orphan Drug Designation Request Granted For BHV- 223 In The Treatment Of |
All times are GMT -5. The time now is 05:41 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.